I said you can use DCF valuations which end up based on price:earnings, I guess my point was price:revenue ratio is only really relevant if it's clear the company can translate revenue to profit or if it's very early... Just IMO.
I didn't say it's better off a tax write off, just an option. But a silver lining in what has been a tough ride with many down 90% odd is that the loss can be realised part of in full, and used to offset a future gain, or can just hold if you believe in the co...
I think the recent announcement flagging significant operating cost reductions and adjustments to remuneration was a big step in the right direction, just need to see it come to fruition.
- Forums
- ASX - By Stock
- KDY
- DW8 Growth
DW8 Growth, page-16001
-
-
- There are more pages in this discussion • 403 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KDY (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.834M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KDY (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online